
Combimist-L Respicap
Marketer
Zydus Cadila
Salt Composition
Levosalbutamol (100mcg) + Ipratropium (40mcg)
Overview Combimist-L Respicap
Combimist-L Respicap treats chronic obstructive pulmonary disease (COPD), a lung condition restricting airflow. It eases breathing by relaxing airway muscles, alleviating coughing, wheezing, and breathlessness. Your physician will determine the appropriate inhaler usage frequency. Benefits become apparent within days, reaching peak effectiveness after several weeks. Consistent use is crucial for efficacy; continued use is vital even without symptoms, indicating its ongoing benefit. Discontinuing treatment may worsen COPD. This medication isn't for sudden breathlessness; use your rescue inhaler instead. Proper inhaler technique is essential for optimal results. Common side effects include dry mouth, shortness of breath, cough, tremors, headache, palpitations, and muscle cramps. While these shouldn't necessitate treatment cessation, consult your doctor. Rinsing your mouth or brushing teeth after inhalation can mitigate some side effects. Less frequent, but potentially serious, side effects warrant medical discussion. Inform your doctor of any kidney or liver conditions, or pregnancy (including plans for pregnancy) or breastfeeding, to ensure appropriate dosage.
Uses of Combimist-L Respicap
Managing chronic obstructive pulmonary disease (COPD), asthma, and bronchitis through therapeutic intervention and preventative measures.
Major Benefits of Combimist-L Respicap:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always refer to the product label for application details.
Common Side effects of Combimist-L Respicap:
- Dryness in mouth
- Cough
- Tremors
- Headache
- Palpitations
- Muscle cramp
- Back pain
- Chest pain
- Fatigue
- Dizziness
- Nausea
- Diarrhea
- Abdominal pain
- Vomiting
- Constipation
- Taste change
- Sore throat
How to use Combimist-L Respicap:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always refer to the product label for administration guidelines.
How Combimist-L Respicap works:
Combimist-L Respicap unites levosalbutamol, a bronchodilator, with ipratropium, an anticholinergic agent. This synergistic effect relaxes airway muscles, increasing airflow, and thus facilitating respiration.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Combimist-L Respicap and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Combimist-L Respicap during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Combimist-L Respicap while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingNone
No drug interactions identified.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Combimist-L Respicap :
Should you forget a Combimist-L Respicap dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Combimist-L Respicap
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
